Encaleret Showed Parathyroid Hormone-Independent Normalization of Blood and Urine Calcium in Phase 2 Proof-of-Concept Study in Post-Surgical Hypoparathyroidism

(NASDAQ:BBIO), – 80% of post-surgical hypoparathyroidism participants achieved concomitant blood and 24-hour urine calcium in the normal reference range within 5 days of encaleret treatment initiation compared to 0% of participants on conventional therapy at baseline – Encaleret was well-tolerated with no serious adverse events reported over the study period – Based on these findings, […]

Encaleret Showed Parathyroid Hormone-Independent Normalization of Blood and Urine Calcium in Phase 2 Proof-of-Concept Study in Post-Surgical Hypoparathyroidism

Encaleret Showed Parathyroid Hormone-Independent Normalization of Blood and Urine Calcium in Phase 2 Proof-of-Concept Study in Post-Surgical Hypoparathyroidism GlobeNewswire September 06, 2025 – 80% of post-surgical hypoparathyroidism participants achieved concomitant blood and 24-hour urine calcium in the normal reference range within 5 days of encaleret treatment initiation compared to 0% of participants on conventional therapy

FLYW DEADLINE: ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Flywire Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – FLYW

NEW YORK CITY, NY / ACCESS Newswire / September 6, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Flywire Corporation (NASDAQ:FLYW) between February 28, 2024 and February 25, 2025, both dates inclusive (the "Class Period"), of the important September 23, 2025 lead plaintiff deadline. SO WHAT:

ANRO DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Alto Neuroscience, Inc. Investors to Secure Counsel Before Important September 19 Deadline in Securities Class Action – ANRO

NEW YORK CITY, NY / ACCESS Newswire / September 6, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Alto Neuroscience, Inc. (NYSE:ANRO): (i) pursuant and/or traceable to Alto’s initial public offering conducted on or about February 2, 2024 (the "IPO"); and/or (ii) securities between February

Real Estate Experts Jim and Mike Savas Explain Accurate Home Pricing in HelloNation

BELMONT, Mass., Sept. 06, 2025 (GLOBE NEWSWIRE) — In an article published in HelloNation, real estate experts The Jim and Mike Savas Team in Belmont, Massachusetts, explain how a miscalculated number at the start can impact every stage of the selling process. The Greater Boston housing market is competitive, but whether conditions are strong or

Real Estate Experts Jim and Mike Savas Explain Accurate Home Pricing in HelloNation

Real Estate Experts Jim and Mike Savas Explain Accurate Home Pricing in HelloNation What happens if you get the listing price of your home wrong? GlobeNewswire September 06, 2025 BELMONT, Mass., Sept. 06, 2025 (GLOBE NEWSWIRE) — In an article published in HelloNation, real estate experts The Jim and Mike Savas Team in Belmont, Massachusetts,

GAC Again Ranks Top 3 in Hong Kong EV Sales with “One GAC 2.0” Strategy Gaining Momentum

According to data from the Government of the Hong Kong Transport Special Administrative Region,AION, under GAC, recorded 399 new vehicle registrations in August, securing its position as a top 3 EV seller in Hong Kong for the second consecutive month since first breaking into the ranking in July. https://mma.prnewswire.com/media/2766526/iMAGE1.jpg On June 12 this year, at

LFMD Investors Have Opportunity to Lead LifeMD, Inc. Securities Fraud Lawsuit First Filed by The Rosen Law Firm

https://mma.prnewswire.com/media/2598307/32a64817_10ba_407b_947c_76bd790799f6_Logo.jpg Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities ofLifeMD, Inc. (NASDAQ: LFMD) between May 7, 2025 and August 5, 2025, both dates inclusive (the “Class Period”), of the important October 27, 2025 lead plaintiff deadline in the securities class action first filed by the Firm. So what: If

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lockheed Martin

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Lockheed Martin To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Lockheed Martin between January 23, 2024 and July 21, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi

TESSAN Debuts “Berlin Castle Night” to Unveil New Brand Experience at IFA 2025

On the opening day ofIFA 2025, TESSAN, a global leader in charging solutions, hosted an exclusive gala dinner, “The Berlin Castle Night.” More than a showcase, the evening represented a profound expression of TESSAN's core brand philosophy, “The Journey Begins at Home,” by shifting the focus from technical specifications to the human stories, emotions, and

Scroll to Top